Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Praecox”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03271242
What this trial is testing

Implementation of National Guidelines for Treatment of Psychoses

Who this might be right for
Psychotic Disorders
University Hospital, Akershus 325
Not applicableLooking for participantsNCT06155682
What this trial is testing

TMS for Inhibition Enhancement in Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 34
Post-approval studies (Phase 4)Study completedNCT00761670
What this trial is testing

Efficacy Study on Cognitive Functions in Schizophrenic Patients

Who this might be right for
Schizophrenia
Sanofi 37
Large-scale testing (Phase 3)Looking for participantsNCT07184619
What this trial is testing

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA 400
Not applicableStudy completedNCT01731171
What this trial is testing

Probiotics to Prevent Relapse After Hospitalization for Mania

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Sheppard Pratt Health System 66
Not applicableStudy completedNCT00161044
What this trial is testing

An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms

Who this might be right for
Chronic Schizophrenia
University of Maryland, Baltimore 20
Post-approval studies (Phase 4)Study completedNCT00290121
What this trial is testing

Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Université de Montréal 25
Early research (Phase 1)Study completedNCT01892384
What this trial is testing

Safety and Tolerability of BI 409306 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Boehringer Ingelheim 40
Testing effectiveness (Phase 2)Study completedNCT02928965
What this trial is testing

The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms

Who this might be right for
Schizophrenia and Disorders With Psychotic Features
University of Manchester 207
Not applicableStudy completedNCT00552500
What this trial is testing

Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia

Who this might be right for
Insulin ResistanceBody Composition
Washington University School of Medicine 120
Post-approval studies (Phase 4)Study completedNCT01811160
What this trial is testing

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

Who this might be right for
Second Generation Antipsychotic Induced Metabolic Adverse Effects
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 50
Not applicableUnknownNCT04106960
What this trial is testing

Quantitative Investigation of Environment and Participation

Who this might be right for
Supported Accommodation ResidentsSchizophrenia, Shizotypal and Delusional DisordersMood Affective Disorders+1 more
Queen Margaret University 235
Post-approval studies (Phase 4)Study completedNCT00486005
What this trial is testing

Weight Gain Management in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 74
Not applicableEnded earlyNCT03741751
What this trial is testing

Repetitive TMS & Cognitive Training in Adults With Schizophrenia

Who this might be right for
Schizophrenia Spectrum and Other Psychotic DisordersCognitive Impairment
Washington University School of Medicine 12
Not applicableNot Yet RecruitingNCT07157293
What this trial is testing

Online Intervention To Improve Motivation

Who this might be right for
Schizophrenia ProdromalSCHIZOPHRENIA 1 (Disorder)Psychosis
University of Alabama at Birmingham 60
Not applicableUnknownNCT01546467
What this trial is testing

Cognitive Remediation in Early Phase Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis NOS
Oslo University Hospital 50
Not applicableUnknownNCT05869409
What this trial is testing

Physical Activity, Psychopathology, and Quality of Life in People With Psychotic or Affective Disorders

Who this might be right for
Psychotic DisordersAffective Disorder
University of Social Sciences and Humanities, Warsaw 60
Not applicableStudy completedNCT00937716
What this trial is testing

Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies

Who this might be right for
Schizophrenia
University of Alabama at Birmingham 75
Early research (Phase 1)Study completedNCT02769936
What this trial is testing

Glutamate, Learning, and Working Memory

Who this might be right for
Schizophrenia
University of California, Los Angeles 110
Early research (Phase 1)Study completedNCT05402111
What this trial is testing

A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 31
Next Page